GlassScriptPhysician profile
Laura B Martin
NPI 1558663534
$4,566.44
in general payments reported to CMS, 2019-2025
38 companies · $1,971 in 2025
The $1,971 reported for 2025 was more than what 93% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $41.31 · 2022: $434 · 2023: $923 · 2024: $1,198 · 2025: $1,971.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,092.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,091.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $761.88 | 2022-2025 | |
| Lilly USA, LLC | $542.77 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $495.79 | 2022-2025 | Caplyta |
| Vanda Pharmaceuticals INC. | $394.30 | 2024-2025 | Fanapt, Hetlioz |
| Novo Nordisk INC | $298.09 | 2022-2025 | Ozempic, Rybelsus |
| Pfizer INC. | $246.80 | 2021-2025 | |
| Glaxosmithkline, LLC. | $242.51 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Astrazeneca Pharmaceuticals LP | $231.52 | 2022-2025 | Farxiga, Breztri, Airsupra |
| Amgen INC. | $139.27 | 2022-2025 | Otezla, Repatha, Repatha |
| Otsuka America Pharmaceutical, INC. | $110.93 | 2024-2025 | Rexulti |
| Axsome Therapeutics, INC. | $107.81 | 2023-2025 | Auvelity, Symbravo |
| Dynavax Technologies Corporation | $104.20 | 2024-2025 | Heplisav-B |
| Phathom Pharmaceuticals, INC. | $101.38 | 2023-2025 | Voquezna |
| Janssen Pharmaceuticals, INC | $81.09 | 2022-2025 | Spravato |
| Verona Pharma, INC. | $72.87 | 2025 | Ohtuvayre |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $56.50 | 2023-2025 | Trintellix |
| Astellas Pharma US INC | $51.63 | 2023-2025 | Myrbetriq, Veozah |
| Abbott Laboratories | $46.55 | 2022-2024 | Freestyle Libre, Freestyle Libre 3 |
| Alkermes, INC. | $42.90 | 2025 | Lybalvi |
| Exact Sciences Corporation | $40.90 | 2024-2025 | Cologuard Collection Kit |
| Medtronic, INC. | $38.35 | 2025 | Minimed 780g |
| Bayer Healthcare Pharmaceuticals INC. | $37.58 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $32.30 | 2022-2023 | |
| Beta Bionics, INC. | $31.09 | 2024 | Ilet Bionic Pancreas |
| Lundbeck LLC | $27.21 | 2025 | Rexulti |
| Almatica Pharma LLC | $25.09 | 2023 | Gralise, Loreev Xr |
| Teva Pharmaceuticals USA, INC. | $23.05 | 2025 | Austedo Xr |
| Abiomed | $21.10 | 2024 | Impella |
| Ultragenyx Pharmaceutical INC. | $19.88 | 2024 | Crysvita |
| Insulet Corporation | $18.67 | 2025 | Omnipod |
| Idorsia Pharmaceuticals US INC | $17.01 | 2023 | Quviviq |
| Kowa Pharmaceuticals America, INC. | $15.99 | 2025 | Zoryve |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.46 | 2025 | Jardiance |
| Hologic Sales and Service, LLC | $15.00 | 2022 | |
| Dexcom, INC. | $14.95 | 2024 | Dexcom G6 Transmitter |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.91 | 2022 | |
| Inspire Medical Systems, INC. | $14.65 | 2023 | Inspire |
| Axonics, INC. | $14.46 | 2024 | Axonics |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Martin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.